Influence of Temporo-occipital Transcranial Magnetic Brain Stimulation on Aversive Episodic Memory Performance (SAME)

November 28, 2023 updated by: Prof. Dominique de Quervain, MD

A Pilot Study on the Influence of Temporo-occipital Transcranial Magnetic Brain Stimulation on Aversive Episodic Memory Performance

A pilot study, examining the effect of repeated transcranial magnetic brain stimulation (rTMS) on the formation of memories with negative valence. The investigators hypothesize that an effective rTMS protocol to reduce memory performance for adverse events can be found.

Study Overview

Study Type

Interventional

Enrollment (Estimated)

105

Phase

  • Not Applicable

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Contact

Study Locations

    • BS
      • Basel, BS, Switzerland, 4055
        • Recruiting
        • University of Basel, Division of Cognitive Neuroscience
        • Contact:

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

  • Adult

Accepts Healthy Volunteers

Yes

Description

Inclusion Criteria:

  • Male or female
  • Generally healthy
  • Normotensive (BP 90/60mmHg - 140/90mmHg)
  • BMI: 19 - 30 kg/m2
  • Age: 18 - 30 years
  • Fluent German-speaking

Exclusion Criteria:

  • Metal in the brain, skull or elsewhere in the body (e.g., splinters, fragments, clips, etc.)
  • Implanted neurostimulator (e.g., DBS, epidural/subdural, VNS)
  • Cardiac pacemaker or intracardiac lines
  • Medication infusion device
  • Nonremovable Piercings in the head area, pivot teeth (retainers are no exclusion criterion)
  • Tattoos (head area) less than 3 months old or older than 20 years
  • Condition after neurosurgery
  • Hearing problems or tinnitus
  • Not able to sit still due to tremor, tics, itching
  • History of repeated syncope
  • Head trauma diagnosed as concussion or associated with loss of consciousness
  • diagnosis of epilepsy, or a convulsion or a seizure in the past of the participant or his/her close family
  • TMS in the past showing problems
  • Surgical procedures to spinal cord
  • Spinal or ventricular derivations
  • Alcohol or drug intake 48 hours before start of visits
  • Regular intake of any medication or CNS-active medication 48h before visit
  • rMT above the limits of rTMS device.

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

  • Primary Purpose: Basic Science
  • Allocation: Randomized
  • Interventional Model: Sequential Assignment
  • Masking: None (Open Label)

Arms and Interventions

Participant Group / Arm
Intervention / Treatment
Experimental: cTBS experiment
Active brain stimulation on the inferior occipital gyrus using the cTBS protocol.

rTMS using cTBS protocol with the following characteristics:

  • Frequency: trains of 50 Hz (3 pulses) every 200ms (frequency of 5 Hz, in the range of theta band)
  • Intensity: 80% of resting motor threshold (rMT)
  • Location: consecutively on the left and right temporo-occipital cortex (MNI coordinates: left hemisphere: -50, -72, 4; right hemisphere:50, -66, 0)
  • Duration: 40 seconds for each hemisphere, 80 seconds in total.
  • Timing: Immediately before viewing pictures in pictorial memory task (off-line)
Sham Comparator: cTBS sham
Sham brain stimulation on the inferior occipital gyrus using the cTBS protocol

rTMS using cTBS protocol with the following characteristics:

  • Frequency: trains of 50 Hz (3 pulses) every 200ms (frequency of 5 Hz, in the range of theta band)
  • Intensity: 0%
  • Location: consecutively on the left and right temporo-occipital cortex (MNI coordinates: left hemisphere: -50, -72, 4; right hemisphere:50, -66, 0)
  • Duration: 40 seconds for each hemisphere, 80 seconds in total.
  • Timing: Immediately before viewing pictures in pictorial memory task (off-line)
Active Comparator: cTBS active control
Active brain stimulation on the right superior frontal cortex using the cTBS protocol

rTMS using cTBS protocol with the following characteristics:

  • Frequency: trains of 50 Hz (3 pulses) every 200ms (frequency of 5 Hz, in the range of theta band)
  • Intensity: 80% of resting motor threshold (rMT)
  • Location: Right superior frontal cortex
  • Duration: 40 seconds for each hemisphere, 80 seconds in total.
  • Timing: Immediately before viewing pictures in pictorial memory task (off-line)
Experimental: High frequency
Active brain stimulation on the inferior occipital gyrus using the 5Hz protocol

rTMS using high frequency protocol with the following characteristics: Frequency: 5 Hz

  • Intensity: 100% of rMT
  • Location: bilateral temporo-occipital cortex (MNI coordinates: left hemisphere: -50, -72, 4; right hemisphere:50, -66, 0)
  • Duration: 2.5 seconds during the presentation of pictures (3 minutes in total)
  • Timing: Only during the picture viewing part of memory task (On-line)
Experimental: Low frequency
Active brain stimulation on the inferior occipital gyrus using the 1Hz protocol

rTMS using Low frequency protocol with the following characteristics:

  • Frequency: 1 Hz
  • Intensity: 110% of rMT
  • Location: temporo-occipital cortex of dominant brain hemisphere (MNI left hemisphere: -50, -72, 4; right hemisphere:50, -66, 0)
  • Duration: 30 minutes, continuously
  • Timing: Starting 10 minutes before and continuing during the picture viewing and valence rating of the pictures of the memory task (on-line).

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
memory recall performance
Time Frame: On average 1 hour after intervention
The difference between valence specific (negative, positive, and neutral) memory performance as assessed by a standard picture recall episodic memory task.
On average 1 hour after intervention

Secondary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Working memory performance
Time Frame: On average 1 hour after intervention
Working memory performance measured by n-back task
On average 1 hour after intervention

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Investigators

  • Study Chair: Dominique de Quervain, Prof. MD, University of Basel, Research Platform Molecular and Cognitive Neuroscience

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (Actual)

June 6, 2023

Primary Completion (Estimated)

May 31, 2024

Study Completion (Estimated)

May 31, 2024

Study Registration Dates

First Submitted

April 14, 2023

First Submitted That Met QC Criteria

April 27, 2023

First Posted (Actual)

May 8, 2023

Study Record Updates

Last Update Posted (Actual)

November 29, 2023

Last Update Submitted That Met QC Criteria

November 28, 2023

Last Verified

November 1, 2023

More Information

Terms related to this study

Other Study ID Numbers

  • 2023-00392 BASEC_Nr

Plan for Individual participant data (IPD)

Plan to Share Individual Participant Data (IPD)?

YES

IPD Plan Description

All IPD (de-identified) that underlie results in a publication will be shared upon reasonable request

IPD Sharing Access Criteria

All IPD (de-identified) that underlie results in a publication will be shared upon reasonable request for scientific purposes. A reasonable request consists of a short description of the scientific purpose. Requests will be reviewed by the team of the principle investigator.

Drug and device information, study documents

Studies a U.S. FDA-regulated drug product

No

Studies a U.S. FDA-regulated device product

No

product manufactured in and exported from the U.S.

No

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Memory, Episodic

Clinical Trials on rTMS (cTBS experiment)

3
Subscribe